Postexposure prophylaxis with bamlanivimab plus etesevimab is not a substitute for vaccination against COVID-19. The Food and Drug Administration (FDA) has expanded the Emergency Use Authorization ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Following the June update that allowed for a lower dose ...

Australian public health units will contact known cases where rabies PEP was initiated in India and completed in Australia.

In a recent study posted to the medRxiv* preprint server, researchers determined evidence for post-exposure vaccination in reducing the mortality rate of coronavirus disease 2019 (COVID-19).

Ensitrelavir significantly reduced the likelihood of developing symptomatic COVID-19 following household exposure compared with placebo. Treatment with ensitrelvir was found to prevent symptomatic ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A single subcutaneous dose of Regeneron’s antibody ...

Over 69.41 million people around the world have been infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and, of these, over 1.49 million people have lost their lives. The ...